×
App Icon
The Standard e-Paper
Home To Bold Columnists
★★★★ - on Play Store
Download Now

US regulator: No evidence yet linking weight-loss drugs to suicidal thoughts

Vocalize Pre-Player Loader

Audio By Vocalize

This image provided by Novo Nordisk in January 2023 shows packaging for the company's Wegovy drug. [AP Photo]

The U.S. Food and Drug Administration said on Thursday its preliminary review did not find evidence that weight-loss drugs such as Novo Nordisk's NOVOb.CO Wegovy were tied to suicidal thoughts and the agency will continue to study the issue.

Still, the FDA, which has listed suicidal thoughts as a potential safety signal for such drugs, said it could not definitively rule out that a small risk may exist due to the limited data available.

Premium Article

Get Full Access for Ksh299/Week.

Fact-first reporting that puts you at the heart of the newsroom. Subscribe for full access.
Continue Reading  →
What you get
  • Unlimited access to all premium content
  • Ad-free browsing experience
  • Mobile-optimised reading
  • Weekly newsletters & digests
Pay via
M - PESA
VISA
Airtel Money
Secure Payments Kenya's most trusted newsroom since 1902
By Kazungu Koome 20 mins ago
Sports
Kenya's Afcon dream is under threat as FKF officials fight
By Stephen Rutto 28 mins ago
Sports
Kenyans now shift focus to Commonwealth Games after shining at Africa meet in Accra
By Ochieng Oyugi 39 mins ago
Sports
New motorsports body up and running with autocross action at Stoni Athi
Sports
Fight for survival now down to one team as Bidco, Sofapaka relegated